Reaching Motion During Functional Activities (REACHRSA)

November 29, 2023 updated by: University Hospital, Ghent

Reaching Motion by the Elderly During Functional Activities. A Comparison Beween a Healthy Control Group and Patients With a Reverse Shoulder Arthroplasty

Taking and moving objects is essential. When this becomes difficult, it affects daily functioning. This study aims to determine movement patterns, at the level of the shoulder, during different functional movements in elderly people aged 60 years and older. Movement patterns of people without shoulder problems and patients with a reverse shoulder prosthesis will be compared. These insights can contribute to improving functional rehabilitation in patients with a reverse shoulder prosthesis (RSA).

Study Overview

Detailed Description

This study aims to investigate how elderly people (60 years and older) without shoulder pain and patients with a reverse shoulder arthroplasty (60 years and older) perform functional reaching movements. Using IMUs (Inertial Measurement Units), the investigators want to look at mode of execution, relational positions of hand, elbow and shoulder in space, in relation to the trunk and each other, and any compensatory movements made by patients with a reverse shoulder arthroplasty.

At the time of testing, participants will first complete a series of questionnaires. These questionnaires will provide information about the daily functioning of all participants. The participants' shoulder strength will also be measured.

After applying the IMUs, the participant will first perform a maximal movement (active for participant) in 4 directions (forward and lateral lifting of arm, hand-to-neck , hand-to-back). Then the researcher will perform the same movements with the participant's arm (passive for participant). This will allow measurement of the maximum active and passive mobility of the shoulder. Next, the participant will be asked to place and take back a number of different objects (both in terms of size and weight) at predetermined heights.

The participants without shoulder pain will be tested once, the participants with a reverse shoulder arthroplasty we want to test 4 times. The participants without shoulder pain will be assigned to the control group. The participants with a reverse shoulder arthroplasty we want to test 4 times to monitor not only their movement pattern, but also any changes in this pattern .

The questionnaires, strength measurement and requested movements will be the same for both groups.

Analysis of these movements will provide us with insights that can help improve the functional rehabilitation of patients with a reverse shoulder prosthesis.

All participants with a reverse shoulder arthroplasty will be recruited at UZ, participants without shoulder pain will be recruited through different channels (these are not patients)

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 60 years and older
  • no shoulder pain + no diagnosis of shoulder problem
  • primary reverse shoulder arthroplasty

Exclusion Criteria:

  • younger than 60 years
  • shoulder pain at moment of testing
  • known shoulder problem ( incl. diagnosis)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Healthy participants
no shoulder pain no shoulder diagnosis 60 years and older
Functional placing and reaching of objects of different weights on different heights
Other: RSA participants
primary reverse shoulder arthroplasty 60 years and older
Functional placing and reaching of objects of different weights on different heights

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
IMU registration (3D kinematics upper limb)
Time Frame: healthy control group: baseline
kinematic registration of performed exercises by all participants
healthy control group: baseline
IMU registration (3D kinematics upper limb)
Time Frame: RSA group: 3 weeks post surgery
kinematic registration of performed exercises by all participants
RSA group: 3 weeks post surgery
IMU registration (3D kinematics upper limb)
Time Frame: RSA group: 6 weeks post surgery
kinematic registration of performed exercises by all participants
RSA group: 6 weeks post surgery
IMU registration (3D kinematics upper limb)
Time Frame: RSA group: 12 weeks post surgery
kinematic registration of performed exercises by all participants
RSA group: 12 weeks post surgery
IMU registration (3D kinematics upper limb)
Time Frame: RSA group: 6 months post surgery
kinematic registration of performed exercises by all participants
RSA group: 6 months post surgery
IMU registration (3D kinematics upper limb)
Time Frame: RSA group: 12 months post surgery
kinematic registration of performed exercises by all participants
RSA group: 12 months post surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SPADI_DV
Time Frame: during procedure

Content: 5 questions for the subscale pain and 8 questions for the disability subscale.

Scoring: numeric rating scale from 1 to 10, with a maximum of 130. The total score is the sum of the sub-scores.

Interpretation: The higher the score the more pain and disability. The lower the score, the better patients perceive their shoulder

during procedure
Constant- Murley Score
Time Frame: during procedure

Content: partially clinical (65 points) and partially PROM (35 points) assessed.

Scoring: The formula to calculate the total score is:" pain (0-15) + ADL (4x (0-5) = 0-20) + mobility (4 x (0-10) = 0-40)

+ strength (0 -25)". Strength will be measured with the arm elevated to 90 ° in the scapular plane using an IDOmeter.

Interpretation: 0-55 points = bad, 56-70 points = mediocre, 71-85 points = good, 86-100 points = excellent score

during procedure
EQ5D5L
Time Frame: during procedure

Content: 5 questions + EQ-5D VAS for general health. Scoring: 5-response scale (from 'no problems' to 'extreme problems') + VAS percentage between 0 (worst imaginable health state) and 100 (best imaginable health state).

Interpretation: VAS score for general health indicates how a patient perceives his general health, Other questions are descriptive for problems in mobility, self-care, usual activities, pain/ discomfort, anxiety/depression

during procedure
VAS-pain
Time Frame: during procedure
Pain is scored between 0 and 10. 0 = no pain, 10= worst possible pain
during procedure
AROM
Time Frame: during procedure

active range of motion for forward flexion, abduction, hand-to-neck, hand-to-back forward flexion and abduction with extended elbow, functional internal and external rotation in standing position.

  • maximal pain free ROM
  • forward flexion and abduction with extended elbow: measured with the EasyAngle (Meloq AB Sweden)
  • hand-to-back and hand-to-neck test : scored as in Constant-Murley Score
during procedure
PROM
Time Frame: during procedure

passive range of motion for forward flexion and abduction

  • maximal pain free ROM
  • measured with the EasyAngle (Meloq AB Sweden)
during procedure
strength
Time Frame: during procedure

strength will be measured for forward flexion in 0° elevation and in 90° elevation with the EasyForce.

FF at 0° elevation: participants will sit on a chair without backrest, both feet on the ground. Arm in neutral rotation, hand in a fist, thumb facing upward FF at 90° elevation: participants will stand, the arm with extended elbow held at 90° elevation (FF). Hand in a fist, thumb facing upward

during procedure

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
AGE
Time Frame: during procedure
specify age of participant
during procedure
GENDER
Time Frame: during procedure
specify age of participant
during procedure
DOMINANCE
Time Frame: during procedure
specify hand dominance of participant
during procedure
height
Time Frame: during procedure
specify participants height
during procedure
weight
Time Frame: during procedure
specify participants weight
during procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: Ann Cools, PhD, University Ghent
  • Principal Investigator: Alexander Van Tongel, PhD, University Hospital Ghent, University Ghent
  • Study Chair: Annelies Maenhout, PhD, University Ghent

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 15, 2023

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

September 30, 2026

Study Registration Dates

First Submitted

November 6, 2023

First Submitted That Met QC Criteria

November 29, 2023

First Posted (Actual)

December 8, 2023

Study Record Updates

Last Update Posted (Actual)

December 8, 2023

Last Update Submitted That Met QC Criteria

November 29, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ONZ-2023-0416

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on IMU (Inertial Measurement Devices)

3
Subscribe